You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for aluminum hydroxide; magnesium trisilicate and what is the scope of freedom to operate?

Aluminum hydroxide; magnesium trisilicate is the generic ingredient in four branded drugs marketed by Pennex, Guardian Drug, Novartis, and Chattem Sanofi, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE
US Patents:0
Tradenames:4
Applicants:4
NDAs:4
Finished Product Suppliers / Packagers: 1
DailyMed Link:ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE at DailyMed

US Patents and Regulatory Information for ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chattem Sanofi GAVISCON aluminum hydroxide; magnesium trisilicate TABLET, CHEWABLE;ORAL 018685-001 Dec 9, 1983 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Chattem Sanofi GAVISCON aluminum hydroxide; magnesium trisilicate TABLET, CHEWABLE;ORAL 018685-002 Dec 9, 1983 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Pennex ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE aluminum hydroxide; magnesium trisilicate TABLET, CHEWABLE;ORAL 089449-001 Nov 27, 1987 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Novartis FOAMICON aluminum hydroxide; magnesium trisilicate TABLET, CHEWABLE;ORAL 072687-001 Jun 28, 1989 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Aluminum Hydroxide; Magnesium Trisilicate

Introduction

Aluminum hydroxide and magnesium trisilicate are key components in antacid medications, widely used to treat gastric hyperacidity, heartburn, and indigestion. This article delves into the market dynamics and financial trajectory of these compounds, highlighting their applications, market growth drivers, and future projections.

Market Size and Growth Projections

The market for aluminum hydroxide and magnesium trisilicate is intertwined with the broader antacid and pharmaceutical markets. Here are some key statistics:

  • The magnesium trisilicate market, which is closely related, was valued at USD 1.2 billion in 2023 and is expected to reach USD 1.8 billion by 2031, growing at a CAGR of 4.5% from 2024 to 2031[1].
  • The aluminum hydroxide market, another crucial component, was valued at USD 1.9 billion in 2022 and is projected to grow to USD 2.94 billion by 2031, with a CAGR of 5% during the forecast period[3].

Applications and Uses

Pharmaceutical Applications

Aluminum hydroxide and magnesium trisilicate are primarily used in antacid formulations to treat conditions such as heartburn, indigestion, and upset stomach. These medications work by reducing the amount of acid in the stomach[5].

  • Antacid Formulations: These compounds are available in various forms, including chewable tablets, gels, and suspensions. For example, Gaviscon Regular Strength Tablets contain aluminum hydroxide and magnesium trisilicate to provide quick relief from gastric hyperacidity[2].

Other Industrial Applications

Beyond pharmaceuticals, these compounds have diverse industrial uses:

  • Water Treatment: Aluminum hydroxide is used in water treatment processes to remove impurities and improve water quality[3].
  • Construction and Automotive: Aluminum hydroxide serves as a flame retardant in materials such as plastics and cables, driven by stringent safety regulations in these industries[3].

Market Drivers

Several factors are driving the growth of the aluminum hydroxide and magnesium trisilicate markets:

Growing Healthcare Needs

  • The increasing prevalence of gastrointestinal disorders and the rising demand for over-the-counter antacid medications are significant drivers. As the global population ages and lifestyle factors contribute to more frequent gastrointestinal issues, the demand for these medications is expected to rise[1][3].

Technological Advancements

  • Improvements in manufacturing methods have enhanced the application diversity and production efficiency of these compounds. Technological advancements, particularly in the pharmaceutical grade segment, have ensured higher purity and compliance with regulatory standards[1][3].

Agricultural Sector

  • Magnesium trisilicate is used as a soil amendment in agriculture, contributing to improved crop yields and soil quality. This application is driven by the expanding agriculture industry and the need for efficient soil amendments[1].

Consumer Awareness and Regulatory Support

  • Rising consumer awareness of health and wellness, including the use of dietary supplements containing magnesium, supports market growth. Additionally, supportive regulations for agricultural and pharmaceutical uses further bolster the market[1].

Market Segmentation

The market for aluminum hydroxide and magnesium trisilicate is segmented based on several criteria:

By Application

  • Pharmaceuticals: Antacid and anti-nausea drugs are the primary applications.
  • Antacids: Over-the-counter medications for heartburn and indigestion.
  • Cosmetics: Used in skincare products for stabilizing formulations and enhancing texture[1][4].

By Product

  • Powdered Magnesium Trisilicate: Used in various industrial and pharmaceutical applications.
  • Granular Magnesium Trisilicate: Often used in food and cosmetic industries.
  • Micronized Magnesium Trisilicate: Used for its fine particle size, particularly in pharmaceuticals[1].

By Geography

  • North America: A significant market due to high demand for antacid medications.
  • Europe: Driven by the expanding pharmaceutical and cosmetic industries.
  • Asia-Pacific: Rapid industrialization and infrastructure development are key drivers[1][3].

Financial Trajectory

The financial outlook for aluminum hydroxide and magnesium trisilicate is positive, driven by the factors mentioned above.

  • Magnesium Trisilicate Market: Expected to grow from USD 1.2 billion in 2023 to USD 1.8 billion by 2031, at a CAGR of 4.5%[1].
  • Aluminum Hydroxide Market: Projected to grow from USD 1.9 billion in 2022 to USD 2.94 billion by 2031, at a CAGR of 5%[3].

Challenges and Restraints

Despite the positive growth trajectory, the market faces some challenges:

  • Environmental Concerns: Volatility in raw material prices and competition from substitute materials are significant restraints. Additionally, environmental concerns and sustainability issues are becoming more critical, necessitating sustainable production practices[3].
  • Regulatory Compliance: Ensuring compliance with stringent pharmaceutical regulations and maintaining high purity standards can be challenging but is crucial for market growth[3].

Key Players

Several key players are involved in the production and distribution of aluminum hydroxide and magnesium trisilicate:

  • Pfizer: Known for its extensive pharmaceutical portfolio.
  • Merck: A major player in the pharmaceutical industry.
  • TCI Chemicals: Specializes in chemical manufacturing.
  • Hovione: Focuses on pharmaceutical ingredients and intermediates.
  • IMCD Group: A global distributor of specialty chemicals and ingredients[1].

Regional Growth

The Middle East & Africa region is witnessing rapid growth due to expanding industrial sectors and increasing infrastructure development. Countries like Saudi Arabia, UAE, and South Africa are driving demand, particularly in the construction and pharmaceutical sectors[3].

Future Outlook

The future outlook for aluminum hydroxide and magnesium trisilicate is promising, driven by increasing demand for antacid medications, technological advancements, and expanding industrial applications.

Emerging Trends

  • Sustainable Production Practices: There is a growing focus on sustainable sourcing and production methods, driven by consumer preference for natural and eco-friendly ingredients[4].
  • Technological Advancements: Continued improvements in manufacturing methods will enhance application diversity and production efficiency[1][3].

Market Opportunities

  • Growing Demand for Antacids: The increasing prevalence of gastrointestinal disorders will continue to drive the demand for over-the-counter antacid medications.
  • Expanding Industrial Applications: The use of aluminum hydroxide in water treatment, construction, and automotive sectors will continue to grow, driven by stringent safety regulations and the need for non-toxic flame-retardant materials[3].
"The market for magnesium trisilicate is driven by several reasons. The need for magnesium trisilicate as an active component in antacid and anti-nausea drugs is increased by the increased frequency of gastrointestinal problems. Market expansion is driven by the agriculture sector's requirement for efficient soil amendments to raise crop yields and soil quality."[1]

Key Takeaways

  • The magnesium trisilicate market is expected to grow from USD 1.2 billion in 2023 to USD 1.8 billion by 2031.
  • The aluminum hydroxide market is projected to grow from USD 1.9 billion in 2022 to USD 2.94 billion by 2031.
  • Growing healthcare needs, technological advancements, and expanding industrial applications are key drivers.
  • Sustainable production practices and regulatory compliance are critical for future growth.
  • The Middle East & Africa region is a significant growth area due to industrial expansion and infrastructure development.

FAQs

What are the primary applications of aluminum hydroxide and magnesium trisilicate?

The primary applications include antacid formulations to treat heartburn, indigestion, and upset stomach, as well as industrial uses such as water treatment and flame retardants in construction and automotive sectors.

What are the key drivers of the magnesium trisilicate market?

Key drivers include the growing healthcare industry, technological advancements in manufacturing, and the expanding agriculture sector's need for efficient soil amendments.

Which regions are expected to see significant growth in the aluminum hydroxide market?

The Middle East & Africa region is expected to witness rapid growth due to expanding industrial sectors and increasing infrastructure development.

What are the potential challenges facing the aluminum hydroxide and magnesium trisilicate markets?

Challenges include environmental concerns, volatility in raw material prices, competition from substitute materials, and ensuring compliance with stringent pharmaceutical regulations.

Who are some of the key players in the production and distribution of aluminum hydroxide and magnesium trisilicate?

Key players include Pfizer, Merck, TCI Chemicals, Hovione, and IMCD Group.

Sources

  1. Market Research Intellect - Magnesium Trisilicate Market Size, Share, Growth & Trends [2024-2031]
  2. RxList - Aluminum Hydroxide/Magnesium Trisilicate: Side Effects, Dosages, Treatment, Interactions, Warnings
  3. SkyQuestT - Aluminum Hydroxide Market Size, Share, Growth Analysis, By Grade
  4. Market Research Intellect - Magnesium Aluminum Silicate Market Size and Projections
  5. Cleveland Clinic - Aluminum Hydroxide; Magnesium Trisilicate chewable tablets

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.